首页> 外国专利> Remedy/preventive for vascular disorders and hypertension and method of screening the same

Remedy/preventive for vascular disorders and hypertension and method of screening the same

机译:血管疾病和高血压的治疗/预防方法及其筛查方法

摘要

It is intended to clarify a transportation system participating in the uric acid uptake in vascular smooth muscle cells (VSMCs) and provide a novel remedy, a preventive or a treating agent for vascular disorders, hypertension and renal disorders with the use of a drug participating in this transportation system. It is also intended to provide a novel screening system for a remedy, a preventive or a treating agent for vascular disorders, hypertension and renal disorders with the use of such a transportation system. Namely, a medicinal composition for healing, preventing or treating vascular disorders, hypertension and renal disorders which comprises a drug having an effect of inhibiting the uric acid uptake by a uric acid transporter URAT1 and a pharmaceutically acceptable carrier; and a method of screening a substance efficacious for healing, preventing or treating vascular disorders, hypertension and renal disorders which comprises using a cell line expressing URAT1 in the presence or absence of a test compound and assaying the uric acid uptake level, cell proliferation ability or the amount of a monocyte chemotactic factor produced by the cells.
机译:旨在阐明参与血管平滑肌细胞(VSMC)中尿酸摄取的运输系统,并通过使用参与其中的药物来提供针对血管疾病,高血压和肾脏疾病的新药,预防剂或治疗剂这个运输系统。还意图通过使用这种运输系统提供用于血管疾病,高血压和肾脏疾病的药物,预防剂或治疗剂的新颖的筛选系统。即,用于治疗,预防或治疗血管疾病,高血压和肾脏疾病的药物组合物,其包含具有抑制尿酸转运蛋白URAT1吸收尿酸的作用的药物和药学上可接受的载体;以及一种筛选对治愈,预防或治疗血管疾病,高血压和肾脏疾病有效的物质的方法,该方法包括在存在或不存在测试化合物的情况下使用表达URAT1的细胞系,并测定尿酸摄取水平,细胞增殖能力或细胞产生的单核细胞趋化因子的量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号